Literature DB >> 19703128

PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis.

Li Sen Hao1, Xiao Lan Zhang, Jun Yan An, Justin Karlin, Xiao Peng Tian, Zhi Na Dun, Shu Rui Xie, Shuang Chen.   

Abstract

The gene phosphatase and tensin homolog deleted on chromosome 10 (PTEN) codes for a tumor-suppressor phospholipid phosphatase. Deletion, mutation or abnormal expression of PTEN is commonly found in many kinds of malignant tumors. At the time of this study, though, the role of PTEN expression in the pathology of hepatic fibrosis remains unclear. In this study, we investigate the dynamic expression of PTEN in a rat model of hepatic fibrosis, with special emphasis on the activation and proliferation of hepatic stellate cells (HSC) in vivo. The rat model of hepatic fibrosis used in this study employed common bile duct ligation. At four time points, the expression of PTEN in hepatic tissues and activated HSC in rat liver tissues was measured by immunohistochemical staining, Western blotting, real-time fluorescent quantitative PCR and immunofluorescence confocal laser scanning microscopy, respectively. Further, alpha-smooth muscle actin (alpha-SMA), an activated HSC marker in rat liver tissues, was detected by immunohistochemical staining. This study showed that aggravation of hepatic fibrosis led to gradually decreasing expression of PTEN in the hepatic tissues. Further, as hepatic fibrosis worsens, PTEN-expressing activated HSC accounts for an increasingly smaller percentage of all activated HSC. In contrast, the percentage of alpha-SMA-expressing HSC cells increases significantly. In conclusion, expression of PTEN mRNA and protein is down-regulated in fibrogenic rat liver tissue, and its expression in HSC in vivo also decreases with progression of fibrosis. Thus, these results show that the dynamic expression of PTEN in hepatic tissues negatively correlates with activation and proliferation of HSC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703128     DOI: 10.1111/j.1600-0463.2009.02515.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  13 in total

1.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma.

Authors:  Weiqi Tan; Yang Li; Seng-Gee Lim; Theresa M C Tan
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

3.  Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.

Authors:  Punnya V Angadi; Rekha Krishnapillai
Journal:  Head Neck Pathol       Date:  2012-03-06

4.  Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.

Authors:  Junyan An; Libo Zheng; Shurui Xie; Fengrong Yin; Xiaoxia Huo; Jian Guo; Xiaolan Zhang
Journal:  Dig Dis Sci       Date:  2015-12-12       Impact factor: 3.199

5.  Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.

Authors:  Andrea Sanchez-Pareja; Sophie Clément; Marion Peyrou; Laurent Spahr; Francesco Negro; Laura Rubbia-Brandt; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

6.  In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis.

Authors:  Guo-Zun Zhang; Hui-Cong Sun; Li-Bo Zheng; Jin-Bo Guo; Xiao-Lan Zhang
Journal:  World J Gastroenterol       Date:  2017-12-14       Impact factor: 5.742

7.  Effects and mechanism of adenovirus-mediated phosphatase and tension homologue deleted on chromosome ten gene on collagen deposition in rat liver fibrosis.

Authors:  Shu-Rui Xie; Jun-Yan An; Li-Bo Zheng; Xiao-Xia Huo; Jian Guo; David Shih; Xiao-Lan Zhang
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

8.  Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists.

Authors:  Efrat Sharvit; Shirley Abramovitch; Shimon Reif; Rafael Bruck
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

9.  The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.

Authors:  Chuan Shen; Cai-Yan Zhao; Wei Wang; Ya-Dong Wang; Hui Sun; Wei Cao; Wei-Yan Yu; Li Zhang; Ru Ji; Meng Li; Jian Gao
Journal:  BMC Gastroenterol       Date:  2014-02-23       Impact factor: 3.067

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.